{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:17:21Z","timestamp":1768702641624,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.clim.2010.06.005","type":"journal-article","created":{"date-parts":[[2010,7,6]],"date-time":"2010-07-06T08:50:16Z","timestamp":1278406216000},"page":"15-20","source":"Crossref","is-referenced-by-count":46,"title":["Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients"],"prefix":"10.1016","volume":"137","author":[{"given":"Trina A.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Shames","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Keezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Lapierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Haegert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Bar-Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Antel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2010.06.005_bib1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","article-title":"Oral fingolimod (FTY720) for relapsing multiple sclerosis","volume":"355","author":"Kappos","year":"2006","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.clim.2010.06.005_bib2","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.clim.2010.06.005_bib3","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.160.10.5037","article-title":"FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats: I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing","volume":"160","author":"Chiba","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2010.06.005_bib4","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.4049\/jimmunol.160.11.5493","volume":"160","author":"Yanagawa","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2010.06.005_bib5","first-page":"11","article-title":"Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus","volume":"3","author":"Chiba","year":"2006","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2010.06.005_bib6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.clim.2010.06.005_bib7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1056\/NEJMoa0907839","article-title":"Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis","volume":"362","author":"Cohen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clim.2010.06.005_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMoa0909494","article-title":"A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis","volume":"362","author":"Kappos","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clim.2010.06.005_bib9","doi-asserted-by":"crossref","unstructured":"T.A. Johnson, Y. Lapierre, A. Bar-Or, and J.P. Antel, Distinct properties of circulating CD8+ T cells in FTY720 treated multiple sclerosis patients. Archives of Neurology (2010) in press.","DOI":"10.1001\/archneurol.2010.312"},{"key":"10.1016\/j.clim.2010.06.005_bib10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1212\/01.wnl.0000327609.57688.ea","article-title":"FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis","volume":"71","author":"Mehling","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clim.2010.06.005_bib11","first-page":"1826","article-title":"FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation","volume":"77","author":"Tedesco-Silva","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2010.06.005_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.clineuro.2004.02.013","article-title":"Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench","volume":"106","author":"Coles","year":"2004","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.clim.2010.06.005_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ana.21867","article-title":"Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial","volume":"66","author":"Hawker","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.clim.2010.06.005_bib14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/0091270004264165","article-title":"Multiple-dose FTY720: tolerability, pharmacokinetics, and lymphocyte responses in healthy subjects","volume":"44","author":"Kovarik","year":"2004","journal-title":"J. Clin. Pharmacol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161000611X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166161000611X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T22:57:43Z","timestamp":1685660263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166161000611X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S152166161000611X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2010.06.005","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}